Cargando…

Shared Decisions: A Qualitative Study on Clinician and Patient Perspectives on Statin Therapy and Statin‐Associated Side Effects

BACKGROUND: Despite guideline recommendations and clinical trial data suggesting benefit, statin therapy use in patients with atherosclerotic cardiovascular disease remains suboptimal. The aim of this study was to understand clinician and patient views on statin therapy, statin‐associated side effec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmed, Sarah T., Akeroyd, Julia M., Mahtta, Dhruv, Street, Richard, Slagle, Jason, Navar, Ann Marie, Stone, Neil J., Ballantyne, Christie M., Petersen, Laura A., Virani, Salim S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763718/ https://www.ncbi.nlm.nih.gov/pubmed/33170055 http://dx.doi.org/10.1161/JAHA.120.017915

Ejemplares similares

Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease
por: Mahtta, Dhruv, et al.
Publicado: (2020)

Leveraging structured and unstructured electronic health record data to detect reasons for suboptimal statin therapy use in patients with atherosclerotic cardiovascular disease
por: Gobbel, Glenn T., et al.
Publicado: (2021)

Statin diabetogenicity: guidance for clinicians
por: Ray, Kausik
Publicado: (2013)

Statin Intolerance: the Clinician’s Perspective
por: Stulc, Tomáš, et al.
Publicado: (2015)

Association of Primary Care Providers’ Beliefs of Statins for Primary Prevention and Statin Prescription
por: Clough, Jeffrey D., et al.
Publicado: (2019)

Communicating statin evidence to support shared decision-making
por: Barrett, Bruce, et al.
Publicado: (2016)

Statin-Induced Diabetes: Will It Change Clinical Practice?
por: Belalcazar, L. Maria, et al.
Publicado: (2009)

Patient‐Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry
por: Bradley, Corey K., et al.
Publicado: (2019)

Racial and geographic disparities in influenza vaccination in the U.S. among individuals with atherosclerotic cardiovascular disease: Renewed importance in the setting of COVID-19
por: Al Rifai, Mahmoud, et al.
Publicado: (2021)

CLEAR Serenity Trial: More Clarity for the Future of Bempedoic Acid in Patients Unable to Take Statins?
por: Jia, Xiaoming, et al.
Publicado: (2019)

Statins in COVID-19 infection: A rehash of old themes or truly a new hope?
por: Jia, Xiaoming, et al.
Publicado: (2021)

Facility-Level Variation in Cardiac Stress Test Use Among Patients With Diabetes: Findings From the Veterans Affairs National Database
por: Mahtta, Dhruv, et al.
Publicado: (2020)

Patient perceptions and use of non‐statin lipid lowering therapy among patients with or at risk for atherosclerotic cardiovascular disease: Insights from the PALM registry
por: Lowenstern, Angela, et al.
Publicado: (2021)

An Informatics Approach to Implement Support for Shared Decision Making for Primary Prevention Statin Therapy
por: Ye, Siqin, et al.
Publicado: (2018)

Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry
por: Xian, Ying, et al.
Publicado: (2019)

Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry
por: Nanna, Michael G., et al.
Publicado: (2018)

Lipid Testing and Statin Dosing After Acute Myocardial Infarction
por: Wang, William T., et al.
Publicado: (2018)

Statin Intolerance and Suboptimal Statin Therapy
por: Tada, Hayato, et al.
Publicado: (2019)

Promise and Perils of Telehealth in the Current Era
por: Mahtta, Dhruv, et al.
Publicado: (2021)

Highlights from Studies Presented at the American Heart Association Scientific Session 2020: Navigating New Roads in Prevention
por: Hussain, Aliza, et al.
Publicado: (2021)

Highlights from Studies Presented at the Virtual American College of Cardiology Scientific Sessions 2021: Staying Updated with the Latest Advancements in Prevention
por: Jain, Vardhmaan, et al.
Publicado: (2021)

Impact of Cost Sharing on Therapeutic Substitution: The Story of Statins in 2006
por: Li, Pengxiang, et al.
Publicado: (2016)

A dataset to assess providers׳ knowledge and attitudes towards the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline
por: Pokharel, Yashashwi, et al.
Publicado: (2016)

Pleotropic effects of statins: the dilemma of wider utilization of statin
por: Choudhary, Ambika, et al.
Publicado: (2023)

Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi‐Ethnic Study of Atherosclerosis)
por: Miedema, Michael D., et al.
Publicado: (2018)

Physicians’ Experiences as Patients with Statin Side Effects: A Case Series
por: Koslik, Hayley J., et al.
Publicado: (2017)

Side Effect Patterns in a Crossover Trial of Statin, Placebo, and No Treatment
por: Howard, James P., et al.
Publicado: (2021)

Safety of statins
por: Maji, Debasish, et al.
Publicado: (2013)

Statins and cancers
por: Stryjkowska-Góra, Aleksandra, et al.
Publicado: (2014)

Non-traditional risk factors and the risk of myocardial infarction in the young in the US population-based cohort
por: Krittanawong, Chayakrit, et al.
Publicado: (2020)

Pattern of statin use changes following media coverage of its side effects
por: Kriegbaum, Margit, et al.
Publicado: (2017)

A multistate transition model for statin‐induced myopathy and statin discontinuation
por: Zhu, Yuxi, et al.
Publicado: (2021)

Statins as antiepileptogenic drugs: Analyzing the evidence and identifying the most promising statin
por: Hufthy, Yousif, et al.
Publicado: (2022)

Racial Disparities in Modifiable Risk Factors and Statin Usage in Black Patients With Familial Hypercholesterolemia
por: Agarwala, Anandita, et al.
Publicado: (2021)

Long-Term Efficacy of Adding Fenofibric Acid to Moderate-Dose Statin Therapy in Patients with Persistent Elevated Triglycerides
por: Ballantyne, Christie M., et al.
Publicado: (2011)

Substance Use and Premature Atherosclerotic Cardiovascular Disease (From the CDC Behavioral Risk Factor Surveillance System [BRFSS] Survey)
por: Daher, Marilyne, et al.
Publicado: (2021)

T cells tamed by statins
por: Van Epps, Heather L.
Publicado: (2006)

The antitumour activities of statins
por: Takahashi, H.K., et al.
Publicado: (2007)

Statins: Past and Present
por: Hajar, Rachel
Publicado: (2011)

Reversible Dysphasia and Statins
por: Davies, Gordon Robert Wyndham
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_8l7vddf3meie9fhnv6n15cmp9d